Relapse ratio for each quartile by normalized plasma histidine level at each observational term.

Univariate analyses of factors associated with VL relapse by 6 months, complete case population (N = 1683)1.

Vishal Goyal (4053730)
Raman Mahajan (505155)
Krishna Pandey (567511)
Shambhu Nath Singh (5879345)
Ravi Shankar Singh (2621221)
Nathalie Strub-Wourgaft (356578)
Fabiana Alves (217602)
Vidya Nand Rabi Das (3876250)
Roshan Kamal Topno (5879348)
Bhawna Sharma (3573842)
Manica Balasegaram (156987)
Caryn Bern (205403)
Allen Hightower (319914)
Suman Rijal (181185)
Sally Ellis (157129)
Temmy Sunyoto (610824)
Sakib Burza (505153)
Nines Lima (5879351)
Pradeep Das (230639)
Jorge Alvar (253327)

October 2018

Univariate analyses of factors associated with VL relapse by 6 months, complete case population (N =...

Kaplan-Meier plot comparing relapse-free survival in patients carrying >90 risk alleles to those carrying <80 risk alleles.

Leila Dorling (3156525)
Siddhartha Kar (510873)
Kyriaki Michailidou (205130)
Louise Hiller (39742)
Anne-Laure Vallier (3156534)
Susan Ingle (3156522)
Richard Hardy (3156537)
Sarah J. Bowden (3156519)
Janet A. Dunn (3156531)
Chris Twelves (3156528)
Christopher J. Poole (3156516)
Carlos Caldas (1042)
Helena M. Earl (695366)
Paul D. P. Pharoah (146906)
Jean E. Abraham (3156513)

July 2016

Kaplan-Meier plot comparing relapse-free survival in patients carrying >90 risk alleles to those ...

Plasma biomarkers regulations in our MS clinical forms.

Marta Tejera-Alhambra (749124)
Armanda Casrouge (64698)
Clara de Andrés (327318)
Ansgar Seyfferth (749125)
Rocío Ramos-Medina (749126)
Bárbara Alonso (327320)
Janet Vega (749127)
Lidia Fernández-Paredes (749128)
Matthew L. Albert (200113)
Silvia Sánchez-Ramón (327324)

June 2015

The combinations of biomarkers were down or up-regulated simultaneously in the individuals. The r...

Trends of cumulative relapse ratio for each quartile by unadjusted plasma histidine level (A), unadjusted CRP level (B), unadjusted TNF-alpha level (C), normalized histidine level (D), normalized CRP level (E), and normalized TNF-alpha level (F).

Tadakazu Hisamatsu (185798)
Nobukazu Ono (185819)
Akira Imaizumi (206932)
Maiko Mori (561512)
Hiroaki Suzuki (574019)
Michihide Uo (185803)
Masaki Hashimoto (185800)
Makoto Naganuma (760340)
Katsuyoshi Matsuoka (185806)
Shinta Mizuno (505067)
Mina T. Kitazume (185804)
Tomoharu Yajima (185808)
Haruhiko Ogata (185813)
Yasushi Iwao (185815)
Toshifumi Hibi (105885)
Takanori Kanai (185812)

October 2015

Blue: 1st quartile, purple: 2nd quartile, pink: 3rd quartile, re...

Cure rates and relapse rates at various time points under ITT, ITT worst case, and per protocol analysis.

Bart Ostyn (194715)
Epco Hasker (116130)
Thomas P. C. Dorlo (321337)
Suman Rijal (181185)
Shyam Sundar (58354)
Jean-Claude Dujardin (56958)
Marleen Boelaert (56961)

June 2014

Cure rates and relapse rates at various time points under ITT, ITT worst case, and per protocol a...

Peaks in the relapse rate.

Lisa Willis (410078)
Trevor A. Graham (410079)
Tomás Alarcón (224873)
Malcolm R. Alison (201259)
Ian P. M. Tomlinson (218767)
Karen M. Page (410080)

May 2013

RFI curves (top) and corresponding relapse rates (bottom) for Models 1–3 as parameters (Model 1)...

Survival analysis for relapse time.

Li, Sheng (5303659)

May 2018

Survival analysis of relapse time between High EPM group and Low EPM group.</p

Disease relapse by three criteria at 12 months for patients classified by baseline MBDA score.

Marjan Ghiti Moghadam (5264447)
Femke B. G. Lamers-Karnebeek (5264453)
Harald E. Vonkeman (538287)
Peter M. ten Klooster (538285)
Janneke Tekstra (3121857)
Annemarie M. Schilder (5264444)
Henk Visser (5264456)
Eric H. Sasso (5264450)
David Chernoff (400733)
Willem F. Lems (759125)
Dirk-Jan van Schaardenburg (56426)
Robert Landewe (4612240)
Hein J. Bernelot Moens (5003462)
Timothy R. D. J. Radstake (168224)
Piet L. C. M. van Riel (176205)
Mart A. F. J. van de Laar (538290)
Tim L. Jansen (235185)

May 2018

Disease relapse by three criteria at 12 months for patients classified by baseline MBDA score.</p

Relapse rates during the post-index persistence period.

Niklas Bergvall (585728)
Charles Makin (585729)
Raquel Lahoz (585730)
Neetu Agashivala (585731)
Ashish Pradhan (585732)
Gorana Capkun (585733)
Allison A. Petrilla (585734)
Swapna U. Karkare (585735)
Catherine Balderston McGuiness (585736)
Jonathan R. Korn (585737)

February 2014

CI, confidence interval. Annualized relapse rates were based on generalized estimating equations ...

Distribution of the number of relapses and reinfections based on the time between episodes.

Arnau Domenech (311729)
Carmen Ardanuy (310594)
Roman Pallares (3214206)
Immaculada Grau (310600)
Salud Santos (398706)
Adela G. De la Campa (5654467)
Josefina Liñares (217412)

March 2013

Distribution of the number of relapses and reinfections based on the time between episodes.</p

Hazard Ratios and 95% Confidence Intervals for Incident Metabolic Syndrome according to Percent Change in Bilirubin Level as a Continuous Variable, and Percent Change in Bilirubin Quartile (Q1-Q4) in Men (n = 6890).

You-Bin Lee (3391988)
Seung-Eun Lee (2456881)
Ji Eun Jun (3391985)
Jae Hwan Jee (3391991)
Ji Cheol Bae (125568)
Sang-Man Jin (584624)
Jae Hyeon Kim (125590)

December 2016

Hazard Ratios and 95% Confidence Intervals for Incident Metabolic Syndrome according to Percent C...

Summary of logistic regression analysis for different MRI measure used as a predictor of early relapse.

Junkai Wang (3092706)
Yunli Fan (3092709)
Yue Dong (428521)
Mengying Ma (3092703)
Yuru Dong (428520)
Yajuan Niu (3092712)
Yin Jiang (428519)
Hong Wang (13528)
Zhiyan Wang (2949291)
Liuzhen Wu (428522)
Hongqiang Sun (324047)
Cailian Cui (145929)

May 2018

Summary of logistic regression analysis for different MRI measure used as a predictor of early re...

Odds ratios and adjusted odds ratios for insulin resistance in quartiles of each parameter.

Jinsook Lim (6433361)
Jimyung Kim (6433364)
Sun Hoe Koo (2155066)
Gye Cheol Kwon (6433367)

March 2019

Odds ratios and adjusted odds ratios for insulin resistance in quartiles of each parameter.</p

Hematocrit of all individuals and the mean concentration of each group with 95%CI on each day before the peak values.

Nattapat Nitinai (17896679)
Worapong Nasomsong (17896682)
Worayon Chuerboonchai (17896685)
Akarawin Tweekittikul (17896688)
Vutthikorn Khingmontri (17896691)
Bawornnan Panuvatvanich (17896694)
Thananut Bangchuad (17896697)
Maynanchaya Pongpraijaroen (17896700)
Tanapol Roongfa-ngarm (17896703)
Vasin Vasikasin (13740747)

February 2024

Hematocrit of all individuals and the mean concentration of each group with 95%CI on each day before...

Frequency histogram showing predicted end-HRSD scores for each patient in their Optimal and their Non-Optimal treatment, as indicated by the treatment selection algorithm.

Robert J. DeRubeis (506938)
Zachary D. Cohen (506939)
Nicholas R. Forand (506940)
Jay C. Fournier (506941)
Lois A. Gelfand (506942)
Lorenzo Lorenzo-Luaces (506943)

January 2014

Frequency histogram showing predicted end-HRSD scores for each patient in their Optimal and their...

Univariate analyses of factors associated with VL relapse by 6 months, complete case population (N = 1683)1.

Vishal Goyal (4053730)
Raman Mahajan (505155)
Krishna Pandey (567511)
Shambhu Nath Singh (5879345)
Ravi Shankar Singh (2621221)
Nathalie Strub-Wourgaft (356578)
Fabiana Alves (217602)
Vidya Nand Rabi Das (3876250)
Roshan Kamal Topno (5879348)
Bhawna Sharma (3573842)
Manica Balasegaram (156987)
Caryn Bern (205403)
Allen Hightower (319914)
Suman Rijal (181185)
Sally Ellis (157129)
Temmy Sunyoto (610824)
Sakib Burza (505153)
Nines Lima (5879351)
Pradeep Das (230639)
Jorge Alvar (253327)

October 2018

Univariate analyses of factors associated with VL relapse by 6 months, complete case population (N =...

Kaplan-Meier plot comparing relapse-free survival in patients carrying >90 risk alleles to those carrying <80 risk alleles.

Leila Dorling (3156525)
Siddhartha Kar (510873)
Kyriaki Michailidou (205130)
Louise Hiller (39742)
Anne-Laure Vallier (3156534)
Susan Ingle (3156522)
Richard Hardy (3156537)
Sarah J. Bowden (3156519)
Janet A. Dunn (3156531)
Chris Twelves (3156528)
Christopher J. Poole (3156516)
Carlos Caldas (1042)
Helena M. Earl (695366)
Paul D. P. Pharoah (146906)
Jean E. Abraham (3156513)

July 2016

Kaplan-Meier plot comparing relapse-free survival in patients carrying >90 risk alleles to those ...

Plasma biomarkers regulations in our MS clinical forms.

Marta Tejera-Alhambra (749124)
Armanda Casrouge (64698)
Clara de Andrés (327318)
Ansgar Seyfferth (749125)
Rocío Ramos-Medina (749126)
Bárbara Alonso (327320)
Janet Vega (749127)
Lidia Fernández-Paredes (749128)
Matthew L. Albert (200113)
Silvia Sánchez-Ramón (327324)

June 2015

The combinations of biomarkers were down or up-regulated simultaneously in the individuals. The r...

Trends of cumulative relapse ratio for each quartile by unadjusted plasma histidine level (A), unadjusted CRP level (B), unadjusted TNF-alpha level (C), normalized histidine level (D), normalized CRP level (E), and normalized TNF-alpha level (F).

Tadakazu Hisamatsu (185798)
Nobukazu Ono (185819)
Akira Imaizumi (206932)
Maiko Mori (561512)
Hiroaki Suzuki (574019)
Michihide Uo (185803)
Masaki Hashimoto (185800)
Makoto Naganuma (760340)
Katsuyoshi Matsuoka (185806)
Shinta Mizuno (505067)
Mina T. Kitazume (185804)
Tomoharu Yajima (185808)
Haruhiko Ogata (185813)
Yasushi Iwao (185815)
Toshifumi Hibi (105885)
Takanori Kanai (185812)

October 2015

Blue: 1st quartile, purple: 2nd quartile, pink: 3rd quartile, re...

Cure rates and relapse rates at various time points under ITT, ITT worst case, and per protocol analysis.

Bart Ostyn (194715)
Epco Hasker (116130)
Thomas P. C. Dorlo (321337)
Suman Rijal (181185)
Shyam Sundar (58354)
Jean-Claude Dujardin (56958)
Marleen Boelaert (56961)

June 2014

Cure rates and relapse rates at various time points under ITT, ITT worst case, and per protocol a...

Peaks in the relapse rate.

Lisa Willis (410078)
Trevor A. Graham (410079)
Tomás Alarcón (224873)
Malcolm R. Alison (201259)
Ian P. M. Tomlinson (218767)
Karen M. Page (410080)

May 2013

RFI curves (top) and corresponding relapse rates (bottom) for Models 1–3 as parameters (Model 1)...

Survival analysis for relapse time.

Li, Sheng (5303659)

May 2018

Survival analysis of relapse time between High EPM group and Low EPM group.</p

Disease relapse by three criteria at 12 months for patients classified by baseline MBDA score.

Marjan Ghiti Moghadam (5264447)
Femke B. G. Lamers-Karnebeek (5264453)
Harald E. Vonkeman (538287)
Peter M. ten Klooster (538285)
Janneke Tekstra (3121857)
Annemarie M. Schilder (5264444)
Henk Visser (5264456)
Eric H. Sasso (5264450)
David Chernoff (400733)
Willem F. Lems (759125)
Dirk-Jan van Schaardenburg (56426)
Robert Landewe (4612240)
Hein J. Bernelot Moens (5003462)
Timothy R. D. J. Radstake (168224)
Piet L. C. M. van Riel (176205)
Mart A. F. J. van de Laar (538290)
Tim L. Jansen (235185)

May 2018

Disease relapse by three criteria at 12 months for patients classified by baseline MBDA score.</p

Relapse rates during the post-index persistence period.

Niklas Bergvall (585728)
Charles Makin (585729)
Raquel Lahoz (585730)
Neetu Agashivala (585731)
Ashish Pradhan (585732)
Gorana Capkun (585733)
Allison A. Petrilla (585734)
Swapna U. Karkare (585735)
Catherine Balderston McGuiness (585736)
Jonathan R. Korn (585737)

February 2014

CI, confidence interval. Annualized relapse rates were based on generalized estimating equations ...

Distribution of the number of relapses and reinfections based on the time between episodes.

Arnau Domenech (311729)
Carmen Ardanuy (310594)
Roman Pallares (3214206)
Immaculada Grau (310600)
Salud Santos (398706)
Adela G. De la Campa (5654467)
Josefina Liñares (217412)

March 2013

Distribution of the number of relapses and reinfections based on the time between episodes.</p

Hazard Ratios and 95% Confidence Intervals for Incident Metabolic Syndrome according to Percent Change in Bilirubin Level as a Continuous Variable, and Percent Change in Bilirubin Quartile (Q1-Q4) in Men (n = 6890).

You-Bin Lee (3391988)
Seung-Eun Lee (2456881)
Ji Eun Jun (3391985)
Jae Hwan Jee (3391991)
Ji Cheol Bae (125568)
Sang-Man Jin (584624)
Jae Hyeon Kim (125590)

December 2016

Hazard Ratios and 95% Confidence Intervals for Incident Metabolic Syndrome according to Percent C...

Summary of logistic regression analysis for different MRI measure used as a predictor of early relapse.

Junkai Wang (3092706)
Yunli Fan (3092709)
Yue Dong (428521)
Mengying Ma (3092703)
Yuru Dong (428520)
Yajuan Niu (3092712)
Yin Jiang (428519)
Hong Wang (13528)
Zhiyan Wang (2949291)
Liuzhen Wu (428522)
Hongqiang Sun (324047)
Cailian Cui (145929)

May 2018

Summary of logistic regression analysis for different MRI measure used as a predictor of early re...

Odds ratios and adjusted odds ratios for insulin resistance in quartiles of each parameter.

Jinsook Lim (6433361)
Jimyung Kim (6433364)
Sun Hoe Koo (2155066)
Gye Cheol Kwon (6433367)

March 2019

Odds ratios and adjusted odds ratios for insulin resistance in quartiles of each parameter.</p

Hematocrit of all individuals and the mean concentration of each group with 95%CI on each day before the peak values.

Nattapat Nitinai (17896679)
Worapong Nasomsong (17896682)
Worayon Chuerboonchai (17896685)
Akarawin Tweekittikul (17896688)
Vutthikorn Khingmontri (17896691)
Bawornnan Panuvatvanich (17896694)
Thananut Bangchuad (17896697)
Maynanchaya Pongpraijaroen (17896700)
Tanapol Roongfa-ngarm (17896703)
Vasin Vasikasin (13740747)

February 2024

Hematocrit of all individuals and the mean concentration of each group with 95%CI on each day before...

Frequency histogram showing predicted end-HRSD scores for each patient in their Optimal and their Non-Optimal treatment, as indicated by the treatment selection algorithm.

Robert J. DeRubeis (506938)
Zachary D. Cohen (506939)
Nicholas R. Forand (506940)
Jay C. Fournier (506941)
Lois A. Gelfand (506942)
Lorenzo Lorenzo-Luaces (506943)

January 2014

Frequency histogram showing predicted end-HRSD scores for each patient in their Optimal and their...

Univariate analyses of factors associated with VL relapse by 6 months, complete case population (N = 1683)1.

Vishal Goyal (4053730)
Raman Mahajan (505155)
Krishna Pandey (567511)
Shambhu Nath Singh (5879345)
Ravi Shankar Singh (2621221)
Nathalie Strub-Wourgaft (356578)
Fabiana Alves (217602)
Vidya Nand Rabi Das (3876250)
Roshan Kamal Topno (5879348)
Bhawna Sharma (3573842)
Manica Balasegaram (156987)
Caryn Bern (205403)
Allen Hightower (319914)
Suman Rijal (181185)
Sally Ellis (157129)
Temmy Sunyoto (610824)
Sakib Burza (505153)
Nines Lima (5879351)
Pradeep Das (230639)
Jorge Alvar (253327)

October 2018

Univariate analyses of factors associated with VL relapse by 6 months, complete case population (N =...

Kaplan-Meier plot comparing relapse-free survival in patients carrying >90 risk alleles to those carrying <80 risk alleles.

Leila Dorling (3156525)
Siddhartha Kar (510873)
Kyriaki Michailidou (205130)
Louise Hiller (39742)
Anne-Laure Vallier (3156534)
Susan Ingle (3156522)
Richard Hardy (3156537)
Sarah J. Bowden (3156519)
Janet A. Dunn (3156531)
Chris Twelves (3156528)
Christopher J. Poole (3156516)
Carlos Caldas (1042)
Helena M. Earl (695366)
Paul D. P. Pharoah (146906)
Jean E. Abraham (3156513)

July 2016

Kaplan-Meier plot comparing relapse-free survival in patients carrying >90 risk alleles to those ...

Plasma biomarkers regulations in our MS clinical forms.

Marta Tejera-Alhambra (749124)
Armanda Casrouge (64698)
Clara de Andrés (327318)
Ansgar Seyfferth (749125)
Rocío Ramos-Medina (749126)
Bárbara Alonso (327320)
Janet Vega (749127)
Lidia Fernández-Paredes (749128)
Matthew L. Albert (200113)
Silvia Sánchez-Ramón (327324)

June 2015

The combinations of biomarkers were down or up-regulated simultaneously in the individuals. The r...

Relapse ratio for each quartile by normalized plasma histidine level at each observational term.

Abstract

Extracted data

Relapse ratio for each quartile by normalized plasma histidine level at each observational term.

Abstract

Extracted data

Related items

Related items